UNSPSC 51283727: Cefuzonam sodium

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6SOU25L22C. European Medicines Agency schedules Cefuzonam sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01141MIG. Cefuzonam sodium generally arises in the molecular formula C16H14N7O5S4.NA. The term 'cefuzonam sodium' is a Japanese Accepted Name designation. Most nations, for tariff and trade purposes, schedule cefuzonam sodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFUZONAM SODIUM remains US FDA's Preferred Term for this commodity. Cefuzonam sodium bears US NLM identifiers UMLS ID C0124795 and NCI Concept Code C98232. SMILES: CO/N=C(/C1CSC(N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CSC4CNNS4)C(=O)[O-].[NA+].

UNSPSC 51283727 Cefuzonam sodium is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The source shows recent opportunities for naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, medical and first aid supplies for emergency response, and direct-to-manufacturer prescription programs — none of which are cefuzonam sodium, a third-generation cephalosporin antibiotic. The mismatch suggests either miscoding in the source data or that cefuzonam sodium procurement, if it occurs at the state and local level, is not reflected in currently posted solicitations.

Recent activity under this code shows a diverse issuing-body mix: Seminole County, Florida (health department procurement), the City of Tampa (fire rescue supplies), the Texas Health and Human Services Commission (pharmacy benefit strategy), and the Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local jurisdictions across Minnesota and Oregon. Geographic concentration appears in the Southeast and Upper Midwest, with Florida and Minnesota showing the most recent solicitation activity. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) for naloxone and drug deactivation systems with annual quantities of 1,900 units and 800 units respectively; the City of Tampa's sealed-bid solicitation 26P00145 (due March 13, 2026, estimated contract value $700,000) for medical and first aid supplies serving the Fire Department Rescue Division; and MMCAP's RFP S1070000015802 (proposals due March 26, 2026) for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson wholesalers, effective July 1, 2026. The Tampa procurement is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount up to $10,000.